nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—Fluorouracil—head and neck cancer	0.233	0.315	CbGbCtD
Tranylcypromine—CYP2D6—Hydroxyurea—head and neck cancer	0.192	0.259	CbGbCtD
Tranylcypromine—CYP1A2—Fluorouracil—head and neck cancer	0.0888	0.12	CbGbCtD
Tranylcypromine—CYP2C9—Fluorouracil—head and neck cancer	0.08	0.108	CbGbCtD
Tranylcypromine—CYP2D6—Vinblastine—head and neck cancer	0.0678	0.0917	CbGbCtD
Tranylcypromine—CYP3A4—Vinblastine—head and neck cancer	0.0431	0.0583	CbGbCtD
Tranylcypromine—CYP3A4—Docetaxel—head and neck cancer	0.0355	0.048	CbGbCtD
Tranylcypromine—Memory loss—Fluorouracil—head and neck cancer	0.00928	0.0545	CcSEcCtD
Tranylcypromine—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.00715	0.042	CcSEcCtD
Tranylcypromine—Numbness—Vinblastine—head and neck cancer	0.00501	0.0294	CcSEcCtD
Tranylcypromine—Sensory loss—Vinblastine—head and neck cancer	0.0048	0.0281	CcSEcCtD
Tranylcypromine—Tenderness—Hydroxyurea—head and neck cancer	0.00435	0.0255	CcSEcCtD
Tranylcypromine—Numbness—Fluorouracil—head and neck cancer	0.00329	0.0193	CcSEcCtD
Tranylcypromine—Sensory loss—Fluorouracil—head and neck cancer	0.00315	0.0185	CcSEcCtD
Tranylcypromine—Tenderness—Fluorouracil—head and neck cancer	0.00313	0.0183	CcSEcCtD
Tranylcypromine—Disorientation—Hydroxyurea—head and neck cancer	0.00308	0.018	CcSEcCtD
Tranylcypromine—Disorientation—Fluorouracil—head and neck cancer	0.00221	0.013	CcSEcCtD
Tranylcypromine—Agranulocytosis—Vinblastine—head and neck cancer	0.00217	0.0127	CcSEcCtD
Tranylcypromine—Drowsiness—Hydroxyurea—head and neck cancer	0.00212	0.0124	CcSEcCtD
Tranylcypromine—Amnesia—Fluorouracil—head and neck cancer	0.00211	0.0124	CcSEcCtD
Tranylcypromine—Haemoglobin—Vinblastine—head and neck cancer	0.0021	0.0123	CcSEcCtD
Tranylcypromine—Haemorrhage—Vinblastine—head and neck cancer	0.00209	0.0122	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00208	0.0122	CcSEcCtD
Tranylcypromine—Blood pressure increased—Docetaxel—head and neck cancer	0.00197	0.0116	CcSEcCtD
Tranylcypromine—Haemoglobin—Hydroxyurea—head and neck cancer	0.00191	0.0112	CcSEcCtD
Tranylcypromine—Haemorrhage—Hydroxyurea—head and neck cancer	0.0019	0.0112	CcSEcCtD
Tranylcypromine—Ataxia—Fluorouracil—head and neck cancer	0.00186	0.0109	CcSEcCtD
Tranylcypromine—Alopecia—Vinblastine—head and neck cancer	0.00184	0.0108	CcSEcCtD
Tranylcypromine—Chills—Hydroxyurea—head and neck cancer	0.00171	0.01	CcSEcCtD
Tranylcypromine—Alopecia—Hydroxyurea—head and neck cancer	0.00168	0.00987	CcSEcCtD
Tranylcypromine—Anaemia—Vinblastine—head and neck cancer	0.00168	0.00985	CcSEcCtD
Tranylcypromine—Leukopenia—Vinblastine—head and neck cancer	0.00163	0.00954	CcSEcCtD
Tranylcypromine—Hypertension—Vinblastine—head and neck cancer	0.00157	0.0092	CcSEcCtD
Tranylcypromine—Anaemia—Hydroxyurea—head and neck cancer	0.00153	0.00899	CcSEcCtD
Tranylcypromine—Leukopenia—Hydroxyurea—head and neck cancer	0.00148	0.0087	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00145	0.00852	CcSEcCtD
Tranylcypromine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00142	0.00836	CcSEcCtD
Tranylcypromine—Anorexia—Vinblastine—head and neck cancer	0.00141	0.00829	CcSEcCtD
Tranylcypromine—Haemoglobin—Fluorouracil—head and neck cancer	0.00138	0.00808	CcSEcCtD
Tranylcypromine—Haemorrhage—Fluorouracil—head and neck cancer	0.00137	0.00804	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00136	0.008	CcSEcCtD
Tranylcypromine—Oedema—Hydroxyurea—head and neck cancer	0.00135	0.00793	CcSEcCtD
Tranylcypromine—Ataxia—Docetaxel—head and neck cancer	0.00134	0.00789	CcSEcCtD
Tranylcypromine—Paraesthesia—Vinblastine—head and neck cancer	0.00133	0.00781	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00132	0.00777	CcSEcCtD
Tranylcypromine—Anorexia—Hydroxyurea—head and neck cancer	0.00129	0.00756	CcSEcCtD
Tranylcypromine—Decreased appetite—Vinblastine—head and neck cancer	0.00129	0.00756	CcSEcCtD
Tranylcypromine—Pain—Vinblastine—head and neck cancer	0.00127	0.00744	CcSEcCtD
Tranylcypromine—Constipation—Vinblastine—head and neck cancer	0.00127	0.00744	CcSEcCtD
Tranylcypromine—Feeling abnormal—Vinblastine—head and neck cancer	0.00122	0.00717	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00121	0.00711	CcSEcCtD
Tranylcypromine—Alopecia—Fluorouracil—head and neck cancer	0.00121	0.0071	CcSEcCtD
Tranylcypromine—Somnolence—Hydroxyurea—head and neck cancer	0.0012	0.00705	CcSEcCtD
Tranylcypromine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00118	0.0069	CcSEcCtD
Tranylcypromine—Abdominal pain—Vinblastine—head and neck cancer	0.00117	0.00688	CcSEcCtD
Tranylcypromine—Pain—Hydroxyurea—head and neck cancer	0.00116	0.00678	CcSEcCtD
Tranylcypromine—Constipation—Hydroxyurea—head and neck cancer	0.00116	0.00678	CcSEcCtD
Tranylcypromine—Vision blurred—Fluorouracil—head and neck cancer	0.00112	0.00659	CcSEcCtD
Tranylcypromine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00111	0.00654	CcSEcCtD
Tranylcypromine—Anaemia—Fluorouracil—head and neck cancer	0.0011	0.00647	CcSEcCtD
Tranylcypromine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00107	0.00627	CcSEcCtD
Tranylcypromine—Leukopenia—Fluorouracil—head and neck cancer	0.00107	0.00626	CcSEcCtD
Tranylcypromine—Asthenia—Vinblastine—head and neck cancer	0.00106	0.00624	CcSEcCtD
Tranylcypromine—Agranulocytosis—Docetaxel—head and neck cancer	0.00103	0.00603	CcSEcCtD
Tranylcypromine—Diarrhoea—Vinblastine—head and neck cancer	0.00101	0.00595	CcSEcCtD
Tranylcypromine—Haemoglobin—Docetaxel—head and neck cancer	0.000994	0.00583	CcSEcCtD
Tranylcypromine—Haemorrhage—Docetaxel—head and neck cancer	0.000989	0.0058	CcSEcCtD
Tranylcypromine—Hepatitis—Docetaxel—head and neck cancer	0.000989	0.0058	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000984	0.00577	CcSEcCtD
Tranylcypromine—Confusional state—Fluorouracil—head and neck cancer	0.000982	0.00576	CcSEcCtD
Tranylcypromine—Dizziness—Vinblastine—head and neck cancer	0.000981	0.00575	CcSEcCtD
Tranylcypromine—Oedema—Fluorouracil—head and neck cancer	0.000974	0.00571	CcSEcCtD
Tranylcypromine—Asthenia—Hydroxyurea—head and neck cancer	0.00097	0.00569	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000953	0.00559	CcSEcCtD
Tranylcypromine—Tachycardia—Fluorouracil—head and neck cancer	0.00095	0.00557	CcSEcCtD
Tranylcypromine—Vomiting—Vinblastine—head and neck cancer	0.000943	0.00553	CcSEcCtD
Tranylcypromine—Headache—Vinblastine—head and neck cancer	0.000929	0.00545	CcSEcCtD
Tranylcypromine—Anorexia—Fluorouracil—head and neck cancer	0.000928	0.00544	CcSEcCtD
Tranylcypromine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000925	0.00543	CcSEcCtD
Tranylcypromine—Flushing—Docetaxel—head and neck cancer	0.000918	0.00538	CcSEcCtD
Tranylcypromine—MAOB—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000913	0.0102	CbGpPWpGaD
Tranylcypromine—Hypotension—Fluorouracil—head and neck cancer	0.00091	0.00534	CcSEcCtD
Tranylcypromine—Dizziness—Hydroxyurea—head and neck cancer	0.000894	0.00525	CcSEcCtD
Tranylcypromine—Chills—Docetaxel—head and neck cancer	0.000888	0.00521	CcSEcCtD
Tranylcypromine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000886	0.00987	CbGpPWpGaD
Tranylcypromine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000885	0.00987	CbGpPWpGaD
Tranylcypromine—Nausea—Vinblastine—head and neck cancer	0.000881	0.00517	CcSEcCtD
Tranylcypromine—Insomnia—Fluorouracil—head and neck cancer	0.000881	0.00517	CcSEcCtD
Tranylcypromine—Paraesthesia—Fluorouracil—head and neck cancer	0.000874	0.00513	CcSEcCtD
Tranylcypromine—Alopecia—Docetaxel—head and neck cancer	0.000874	0.00513	CcSEcCtD
Tranylcypromine—Somnolence—Fluorouracil—head and neck cancer	0.000866	0.00508	CcSEcCtD
Tranylcypromine—Vomiting—Hydroxyurea—head and neck cancer	0.00086	0.00504	CcSEcCtD
Tranylcypromine—Rash—Hydroxyurea—head and neck cancer	0.000853	0.005	CcSEcCtD
Tranylcypromine—Dermatitis—Hydroxyurea—head and neck cancer	0.000852	0.005	CcSEcCtD
Tranylcypromine—Headache—Hydroxyurea—head and neck cancer	0.000847	0.00497	CcSEcCtD
Tranylcypromine—Decreased appetite—Fluorouracil—head and neck cancer	0.000846	0.00496	CcSEcCtD
Tranylcypromine—Pain—Fluorouracil—head and neck cancer	0.000833	0.00488	CcSEcCtD
Tranylcypromine—Muscle spasms—Docetaxel—head and neck cancer	0.000828	0.00486	CcSEcCtD
Tranylcypromine—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000805	0.00898	CbGpPWpGaD
Tranylcypromine—Nausea—Hydroxyurea—head and neck cancer	0.000803	0.00471	CcSEcCtD
Tranylcypromine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000802	0.00471	CcSEcCtD
Tranylcypromine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000802	0.00894	CbGpPWpGaD
Tranylcypromine—Anaemia—Docetaxel—head and neck cancer	0.000796	0.00467	CcSEcCtD
Tranylcypromine—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000774	0.00863	CbGpPWpGaD
Tranylcypromine—Urticaria—Fluorouracil—head and neck cancer	0.000773	0.00454	CcSEcCtD
Tranylcypromine—Syncope—Docetaxel—head and neck cancer	0.000772	0.00453	CcSEcCtD
Tranylcypromine—Leukopenia—Docetaxel—head and neck cancer	0.000771	0.00452	CcSEcCtD
Tranylcypromine—Body temperature increased—Fluorouracil—head and neck cancer	0.00077	0.00451	CcSEcCtD
Tranylcypromine—Palpitations—Docetaxel—head and neck cancer	0.000761	0.00446	CcSEcCtD
Tranylcypromine—Loss of consciousness—Docetaxel—head and neck cancer	0.000757	0.00444	CcSEcCtD
Tranylcypromine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00075	0.00836	CbGpPWpGaD
Tranylcypromine—Hypertension—Docetaxel—head and neck cancer	0.000743	0.00436	CcSEcCtD
Tranylcypromine—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000741	0.00826	CbGpPWpGaD
Tranylcypromine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.00074	0.00824	CbGpPWpGaD
Tranylcypromine—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000734	0.00819	CbGpPWpGaD
Tranylcypromine—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.00072	0.00803	CbGpPWpGaD
Tranylcypromine—Dry mouth—Docetaxel—head and neck cancer	0.000717	0.00421	CcSEcCtD
Tranylcypromine—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000712	0.00794	CbGpPWpGaD
Tranylcypromine—Confusional state—Docetaxel—head and neck cancer	0.000709	0.00416	CcSEcCtD
Tranylcypromine—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000706	0.00787	CbGpPWpGaD
Tranylcypromine—Oedema—Docetaxel—head and neck cancer	0.000703	0.00412	CcSEcCtD
Tranylcypromine—Shock—Docetaxel—head and neck cancer	0.000691	0.00406	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000688	0.00404	CcSEcCtD
Tranylcypromine—Tachycardia—Docetaxel—head and neck cancer	0.000686	0.00402	CcSEcCtD
Tranylcypromine—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000683	0.00761	CbGpPWpGaD
Tranylcypromine—Anorexia—Docetaxel—head and neck cancer	0.00067	0.00393	CcSEcCtD
Tranylcypromine—Diarrhoea—Fluorouracil—head and neck cancer	0.000666	0.00391	CcSEcCtD
Tranylcypromine—Hypotension—Docetaxel—head and neck cancer	0.000657	0.00385	CcSEcCtD
Tranylcypromine—MAOA—Biological oxidations—NAT2—head and neck cancer	0.00065	0.00724	CbGpPWpGaD
Tranylcypromine—Dizziness—Fluorouracil—head and neck cancer	0.000644	0.00378	CcSEcCtD
Tranylcypromine—Insomnia—Docetaxel—head and neck cancer	0.000636	0.00373	CcSEcCtD
Tranylcypromine—Paraesthesia—Docetaxel—head and neck cancer	0.000631	0.0037	CcSEcCtD
Tranylcypromine—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000627	0.00699	CbGpPWpGaD
Tranylcypromine—Somnolence—Docetaxel—head and neck cancer	0.000625	0.00366	CcSEcCtD
Tranylcypromine—Vomiting—Fluorouracil—head and neck cancer	0.000619	0.00363	CcSEcCtD
Tranylcypromine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000619	0.0069	CbGpPWpGaD
Tranylcypromine—Rash—Fluorouracil—head and neck cancer	0.000614	0.0036	CcSEcCtD
Tranylcypromine—Dermatitis—Fluorouracil—head and neck cancer	0.000613	0.0036	CcSEcCtD
Tranylcypromine—Decreased appetite—Docetaxel—head and neck cancer	0.000611	0.00358	CcSEcCtD
Tranylcypromine—Headache—Fluorouracil—head and neck cancer	0.00061	0.00358	CcSEcCtD
Tranylcypromine—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000603	0.00673	CbGpPWpGaD
Tranylcypromine—Constipation—Docetaxel—head and neck cancer	0.000601	0.00352	CcSEcCtD
Tranylcypromine—Pain—Docetaxel—head and neck cancer	0.000601	0.00352	CcSEcCtD
Tranylcypromine—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000598	0.00667	CbGpPWpGaD
Tranylcypromine—Feeling abnormal—Docetaxel—head and neck cancer	0.000579	0.0034	CcSEcCtD
Tranylcypromine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000579	0.00645	CbGpPWpGaD
Tranylcypromine—Nausea—Fluorouracil—head and neck cancer	0.000578	0.00339	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000575	0.00337	CcSEcCtD
Tranylcypromine—MAOA—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000573	0.00638	CbGpPWpGaD
Tranylcypromine—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000556	0.00619	CbGpPWpGaD
Tranylcypromine—Body temperature increased—Docetaxel—head and neck cancer	0.000556	0.00326	CcSEcCtD
Tranylcypromine—Abdominal pain—Docetaxel—head and neck cancer	0.000556	0.00326	CcSEcCtD
Tranylcypromine—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00055	0.00613	CbGpPWpGaD
Tranylcypromine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000548	0.00611	CbGpPWpGaD
Tranylcypromine—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000541	0.00603	CbGpPWpGaD
Tranylcypromine—CYP2E1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000536	0.00598	CbGpPWpGaD
Tranylcypromine—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000527	0.00587	CbGpPWpGaD
Tranylcypromine—MAOB—Biological oxidations—GSTM1—head and neck cancer	0.000511	0.0057	CbGpPWpGaD
Tranylcypromine—CYP2A6—Biological oxidations—NAT2—head and neck cancer	0.000504	0.00562	CbGpPWpGaD
Tranylcypromine—Asthenia—Docetaxel—head and neck cancer	0.000504	0.00296	CcSEcCtD
Tranylcypromine—CYP2A6—NRF2 pathway—TGFA—head and neck cancer	0.000489	0.00545	CbGpPWpGaD
Tranylcypromine—MAOB—Biological oxidations—CYP1A1—head and neck cancer	0.000485	0.0054	CbGpPWpGaD
Tranylcypromine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000484	0.0054	CbGpPWpGaD
Tranylcypromine—Diarrhoea—Docetaxel—head and neck cancer	0.000481	0.00282	CcSEcCtD
Tranylcypromine—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000466	0.0052	CbGpPWpGaD
Tranylcypromine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000466	0.00519	CbGpPWpGaD
Tranylcypromine—Dizziness—Docetaxel—head and neck cancer	0.000465	0.00273	CcSEcCtD
Tranylcypromine—Vomiting—Docetaxel—head and neck cancer	0.000447	0.00262	CcSEcCtD
Tranylcypromine—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000445	0.00496	CbGpPWpGaD
Tranylcypromine—Rash—Docetaxel—head and neck cancer	0.000443	0.0026	CcSEcCtD
Tranylcypromine—Dermatitis—Docetaxel—head and neck cancer	0.000443	0.0026	CcSEcCtD
Tranylcypromine—Headache—Docetaxel—head and neck cancer	0.00044	0.00258	CcSEcCtD
Tranylcypromine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000433	0.00483	CbGpPWpGaD
Tranylcypromine—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000428	0.00477	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—UROD—head and neck cancer	0.000426	0.00475	CbGpPWpGaD
Tranylcypromine—Nausea—Docetaxel—head and neck cancer	0.000417	0.00245	CcSEcCtD
Tranylcypromine—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000411	0.00458	CbGpPWpGaD
Tranylcypromine—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.00041	0.00457	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—NAT2—head and neck cancer	0.000399	0.00444	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—NAT2—head and neck cancer	0.000393	0.00438	CbGpPWpGaD
Tranylcypromine—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000391	0.00436	CbGpPWpGaD
Tranylcypromine—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000387	0.00431	CbGpPWpGaD
Tranylcypromine—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000356	0.00397	CbGpPWpGaD
Tranylcypromine—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000353	0.00393	CbGpPWpGaD
Tranylcypromine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000351	0.00392	CbGpPWpGaD
Tranylcypromine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000334	0.00373	CbGpPWpGaD
Tranylcypromine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00033	0.00368	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000322	0.00359	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000322	0.00359	CbGpPWpGaD
Tranylcypromine—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000322	0.00359	CbGpPWpGaD
Tranylcypromine—MAOA—Biological oxidations—GSTM1—head and neck cancer	0.000321	0.00358	CbGpPWpGaD
Tranylcypromine—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000313	0.00349	CbGpPWpGaD
Tranylcypromine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000308	0.00343	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000308	0.00343	CbGpPWpGaD
Tranylcypromine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000305	0.0034	CbGpPWpGaD
Tranylcypromine—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000305	0.00339	CbGpPWpGaD
Tranylcypromine—MAOA—Biological oxidations—CYP1A1—head and neck cancer	0.000304	0.00339	CbGpPWpGaD
Tranylcypromine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000304	0.00338	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000303	0.00338	CbGpPWpGaD
Tranylcypromine—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000301	0.00336	CbGpPWpGaD
Tranylcypromine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000301	0.00335	CbGpPWpGaD
Tranylcypromine—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	0.000284	0.00317	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000283	0.00315	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.00028	0.00313	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000279	0.00311	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000277	0.00308	CbGpPWpGaD
Tranylcypromine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000271	0.00302	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—UROD—head and neck cancer	0.000268	0.00298	CbGpPWpGaD
Tranylcypromine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000261	0.0029	CbGpPWpGaD
Tranylcypromine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000257	0.00287	CbGpPWpGaD
Tranylcypromine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000249	0.00278	CbGpPWpGaD
Tranylcypromine—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	0.000249	0.00278	CbGpPWpGaD
Tranylcypromine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000249	0.00277	CbGpPWpGaD
Tranylcypromine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000247	0.00276	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.00024	0.00267	CbGpPWpGaD
Tranylcypromine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000239	0.00266	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000236	0.00263	CbGpPWpGaD
Tranylcypromine—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.000236	0.00263	CbGpPWpGaD
Tranylcypromine—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00023	0.00256	CbGpPWpGaD
Tranylcypromine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000211	0.00235	CbGpPWpGaD
Tranylcypromine—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00021	0.00234	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—UROD—head and neck cancer	0.000208	0.00232	CbGpPWpGaD
Tranylcypromine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000202	0.00226	CbGpPWpGaD
Tranylcypromine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000201	0.00224	CbGpPWpGaD
Tranylcypromine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000198	0.00221	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000197	0.00219	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000194	0.00216	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000192	0.00214	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000187	0.00208	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000185	0.00206	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000184	0.00205	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000182	0.00203	CbGpPWpGaD
Tranylcypromine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000179	0.002	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000178	0.00198	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—NAT2—head and neck cancer	0.000177	0.00197	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—UROD—head and neck cancer	0.000164	0.00183	CbGpPWpGaD
Tranylcypromine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000163	0.00182	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—DPYD—head and neck cancer	0.000155	0.00173	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000154	0.00172	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000152	0.00169	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000151	0.00168	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.00015	0.00167	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—YAP1—head and neck cancer	0.000147	0.00164	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000144	0.00161	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000142	0.00158	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.00014	0.00156	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000138	0.00154	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000138	0.00154	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000137	0.00152	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000136	0.00151	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000136	0.00151	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000136	0.00151	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000132	0.00148	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000131	0.00146	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000131	0.00146	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000129	0.00144	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—UROD—head and neck cancer	0.000127	0.00141	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000118	0.00132	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000117	0.0013	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—UROD—head and neck cancer	0.000116	0.0013	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—UROD—head and neck cancer	0.000115	0.00129	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000114	0.00127	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000112	0.00125	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NAT2—head and neck cancer	0.000111	0.00124	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000111	0.00123	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000109	0.00122	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—UROD—head and neck cancer	9.87e-05	0.0011	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	9.83e-05	0.0011	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—DPYD—head and neck cancer	9.74e-05	0.00109	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—YAP1—head and neck cancer	9.25e-05	0.00103	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	9.13e-05	0.00102	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—HRAS—head and neck cancer	9.13e-05	0.00102	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	9.01e-05	0.001	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.96e-05	0.000999	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—TYMS—head and neck cancer	8.85e-05	0.000986	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GSTM1—head and neck cancer	8.75e-05	0.000975	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—MAPK1—head and neck cancer	8.71e-05	0.000971	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	8.66e-05	0.000965	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NAT2—head and neck cancer	8.63e-05	0.000962	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	8.54e-05	0.000952	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GPX1—head and neck cancer	8.38e-05	0.000934	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CYP1A1—head and neck cancer	8.29e-05	0.000924	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.66e-05	0.000854	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—UROD—head and neck cancer	7.62e-05	0.000849	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—DPYD—head and neck cancer	7.56e-05	0.000843	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—YAP1—head and neck cancer	7.18e-05	0.0008	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—HRAS—head and neck cancer	6.99e-05	0.00078	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NAT2—head and neck cancer	6.82e-05	0.00076	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—DPYD—head and neck cancer	5.98e-05	0.000666	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—YAP1—head and neck cancer	5.67e-05	0.000632	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.59e-05	0.000623	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—TYMS—head and neck cancer	5.55e-05	0.000619	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.53e-05	0.000616	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTM1—head and neck cancer	5.49e-05	0.000612	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NAT2—head and neck cancer	5.26e-05	0.000586	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GPX1—head and neck cancer	5.26e-05	0.000586	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP1A1—head and neck cancer	5.2e-05	0.00058	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.09e-05	0.000568	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.04e-05	0.000562	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTGS2—head and neck cancer	4.93e-05	0.00055	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NAT2—head and neck cancer	4.84e-05	0.000539	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NAT2—head and neck cancer	4.8e-05	0.000535	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—DPYD—head and neck cancer	4.61e-05	0.000514	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—YAP1—head and neck cancer	4.38e-05	0.000488	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.35e-05	0.000485	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—TYMS—head and neck cancer	4.31e-05	0.00048	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.31e-05	0.00048	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTEN—head and neck cancer	4.3e-05	0.000479	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTM1—head and neck cancer	4.26e-05	0.000475	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—DPYD—head and neck cancer	4.24e-05	0.000473	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—DPYD—head and neck cancer	4.21e-05	0.000469	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NAT2—head and neck cancer	4.1e-05	0.000457	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GPX1—head and neck cancer	4.08e-05	0.000455	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP1A1—head and neck cancer	4.04e-05	0.00045	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—YAP1—head and neck cancer	4.03e-05	0.000449	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—YAP1—head and neck cancer	3.99e-05	0.000445	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—DPYD—head and neck cancer	3.59e-05	0.000401	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—YAP1—head and neck cancer	3.41e-05	0.00038	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—TYMS—head and neck cancer	3.41e-05	0.00038	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTM1—head and neck cancer	3.37e-05	0.000375	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.29e-05	0.000367	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GPX1—head and neck cancer	3.22e-05	0.000359	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP1A1—head and neck cancer	3.19e-05	0.000356	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NAT2—head and neck cancer	3.16e-05	0.000353	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS2—head and neck cancer	3.09e-05	0.000345	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PIK3CA—head and neck cancer	3.03e-05	0.000338	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3e-05	0.000334	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.87e-05	0.00032	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—DPYD—head and neck cancer	2.77e-05	0.000309	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTEN—head and neck cancer	2.7e-05	0.000301	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—YAP1—head and neck cancer	2.63e-05	0.000293	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TYMS—head and neck cancer	2.63e-05	0.000293	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.61e-05	0.000291	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.6e-05	0.00029	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.56e-05	0.000286	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GPX1—head and neck cancer	2.49e-05	0.000277	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—AKT1—head and neck cancer	2.48e-05	0.000276	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.46e-05	0.000275	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TYMS—head and neck cancer	2.42e-05	0.000269	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS2—head and neck cancer	2.4e-05	0.000268	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TYMS—head and neck cancer	2.4e-05	0.000267	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.39e-05	0.000266	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.37e-05	0.000264	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GPX1—head and neck cancer	2.29e-05	0.000255	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GPX1—head and neck cancer	2.27e-05	0.000253	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.26e-05	0.000252	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.25e-05	0.00025	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.23e-05	0.000249	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTEN—head and neck cancer	2.09e-05	0.000234	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TYMS—head and neck cancer	2.05e-05	0.000228	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.02e-05	0.000226	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.02e-05	0.000226	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GPX1—head and neck cancer	1.94e-05	0.000216	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.92e-05	0.000214	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CA—head and neck cancer	1.9e-05	0.000212	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS2—head and neck cancer	1.9e-05	0.000212	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.84e-05	0.000206	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTEN—head and neck cancer	1.66e-05	0.000185	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.58e-05	0.000176	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.58e-05	0.000176	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.56e-05	0.000174	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AKT1—head and neck cancer	1.55e-05	0.000173	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.5e-05	0.000167	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.48e-05	0.000165	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CA—head and neck cancer	1.48e-05	0.000165	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.46e-05	0.000163	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.35e-05	0.00015	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.34e-05	0.000149	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTEN—head and neck cancer	1.28e-05	0.000142	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AKT1—head and neck cancer	1.21e-05	0.000135	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTEN—head and neck cancer	1.17e-05	0.000131	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CA—head and neck cancer	1.17e-05	0.00013	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTEN—head and neck cancer	1.16e-05	0.00013	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.14e-05	0.000127	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTEN—head and neck cancer	9.95e-06	0.000111	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AKT1—head and neck cancer	9.54e-06	0.000106	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	9.01e-06	0.0001	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS2—head and neck cancer	8.81e-06	9.82e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	8.29e-06	9.24e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	8.22e-06	9.16e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTEN—head and neck cancer	7.68e-06	8.56e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AKT1—head and neck cancer	7.36e-06	8.2e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	7.02e-06	7.83e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AKT1—head and neck cancer	6.77e-06	7.55e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AKT1—head and neck cancer	6.71e-06	7.48e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKT1—head and neck cancer	5.73e-06	6.39e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.42e-06	6.04e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKT1—head and neck cancer	4.43e-06	4.93e-05	CbGpPWpGaD
